Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
Figure 1
Percent of survival in ischemia model in Mongolian gerbil, evaluating different doses of intranasal formulation of Neuro-EPO *(); **(,0.02) indicate significant difference in Kaplan Miller Test respect with vehicle ( per group).